Meeting
2017 ASCO Annual Meeting
SWOG S0221 updated: Randomized comparison of chemotherapy schedules in breast cancer adjuvant therapy.
Authors
G. Thomas Budd
Cleveland Clinic, Cleveland, OH
G. Thomas Budd , William E. Barlow , Halle C. F. Moore , Timothy J. Hobday , James A. Stewart , Claudine Isaacs , Muhammad Salim , Jonathan K. Cho , Kristine Rinn , Kathy S. Albain , Helen K. Chew , Gary Von Burton , Timothy David Moore , Gordan Srkalovic , Bradley Alexander McGregor , Lawrence E. Flaherty , Robert B. Livingston , Danika L Lew , Julie Gralow , Gabriel N. Hortobagyi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Adjuvant Therapy
Clinical Trial Registration Number
NCT00070564
Citation
J Clin Oncol 35, 2017 (suppl; abstr 521)
DOI
10.1200/JCO.2017.35.15_suppl.521
Abstract #
521
Poster Bd #
121
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
A multicenter audit of the incidence of febrile neutropenia and neutropenia associated with docetaxel and cyclophosphamide (TC) chemotherapy for early breast cancer.
First Author: Roopa Lakhanpal
Poster
2023 ASCO Annual Meeting
Oral paclitaxel, carboplatin, and dostarlimab (OPE/Cb/D) without and with trastuzumab in early-stage, high-risk breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL.
First Author: Kay T Yeung
Poster
2019 ASCO Annual Meeting
ALEXANDRA/IMpassion030: A phase III study of standard adjuvant chemotherapy with or without atezolizumab in early-stage triple-negative breast cancer.
First Author: Heather L. McArthur
Poster
2018 ASCO Annual Meeting
Symptom burden and employment status in breast cancer (BC) survivors.
First Author: Ines Maria Vaz Duarte Luis